Foley attorneys filed an amicus brief in the United States District Court for the Southern District of New York related to ACLU v. Myriad regarding subject matter patentability of gene patents specifically on isolated DNA. The authors conclude that the U.S. Congress, U.S. courts and the USPTO, as well as the scientific community and biotechnology industry have long relied upon an understanding that claims directed to “isolated DNA” recite patentable subject matter under 35 U.S.C. §101 and the Constitution. The authors maintain that to hold otherwise would have a dramatic negative effect on biotech research as we know it, and will influence the entire business of biotechnology in ways unforeseen or addressed by the plaintiffs in ACLU v. Myriad”
People
Related News
October 8, 2026
Press Releases
Foley Adds Former DOJ and FTC Antitrust Official Jonathan Lasken in Washington, D.C.
Foley & Lardner LLP announced today that Jonathan Lasken has joined the firm’s Washington, D.C. office as a partner in its Antitrust & Competition Practice Group, further strengthening the firm’s capabilities in high-stakes antitrust litigation, government investigations and enforcement, and merger review.
September 10, 2026
Press Releases
Foley Expands Private Capital and Energy Capabilities with Arrival of Corporate Partner Stephen Olson
Foley & Lardner LLP announced today that Stephen Olson has joined the firm as a partner in its Transactions Practice Group, further enhancing Foley’s private capital capabilities and continuing the growth of its national Energy & Infrastructure Sector. Olson joins from Gibson, Dunn & Crutcher LLP in Houston and is regarded as a leading adviser on sophisticated private equity deals and related corporate matters.
September 3, 2026
Press Releases
Foley Strengthens Corporate Platform with Partner Additions in Chicago and Boston
Foley & Lardner LLP announced today that corporate partners Brad Drake and Kyle Pine have joined the firm, bringing Foley to more than 20 lateral partner hires this year and advancing the firm’s strategic expansion across key markets, practices, and sectors.